Related Experiment Video
Updated: Jan 7, 2026

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
Published on: March 11, 2017
Exploration of Extended-Release Lorazepam: Implications for Safe Nurse Practitioner Practice
The U.S. Food and Drug Administration approved Loreev XR®, a new extended-release lorazepam formulation. This article reviews its properties and safe prescribing considerations for nurse practitioners managing anxiety and insomnia.
Area of Science:
- Pharmacology
- Clinical Pharmacy
Background:
- Benzodiazepines (BZDs), including lorazepam, are widely prescribed for anxiety, insomnia, and stress.
- Established risks include dependence, withdrawal, cognitive impairment, and interactions with CNS depressants.
- Nurse practitioners (NPs) play a crucial role in managing these conditions.
Purpose of the Study:
- To examine the rationale for the new extended-release lorazepam formulation, Loreev XR®.
- To differentiate its pharmacokinetic and pharmacodynamic properties from immediate-release lorazepam.
- To outline implications for safe prescribing practices by NPs.
Main Methods:
- Review of pharmacokinetic and pharmacodynamic data for extended-release lorazepam.
- Analysis of clinical considerations for NPs in managing patients on benzodiazepines.
- Emphasis on risk assessment, patient monitoring, and evidence-based tapering strategies.
Main Results:
- Loreev XR® offers a long-acting formulation of lorazepam, approved in 2021.
- Understanding its unique properties is essential for safe and effective patient management.
- NPs require guidance on integrating this new formulation into practice.
Conclusions:
- Extended-release lorazepam presents new considerations for NPs managing anxiety and insomnia.
- Safe prescribing necessitates thorough patient assessment, risk evaluation, and careful monitoring.
- NPs are pivotal in ensuring safe transitions of care and implementing evidence-based tapering protocols for benzodiazepine use.
More Related Videos
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
Related Concept Videos
Anxiolytic Drugs: Benzodiazepines and Buspirone
CNS Depressants: Barbiturates and Benzodiazepines
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Factors Affecting Drug Response: Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...